Immuron (IMRN) Gross Profit (2016 - 2024)
Immuron (IMRN) recorded quarterly Gross Profit of -$1737594727.2 billion in Q4 2024, down 109950132958505.31% quarter-over-quarter from $1.6 million in Q4 2023, and down 109950132958505.31% on a YoY basis from N/an in Q1 2024.
Immuron (IMRN) Gross Profit (2016 - 2024) Analysis & Trends
Immuron's Gross Profit history runs 9 years deep, the most recent figure standing at -$1737594727.2 billion for Q4 2024.
- In Q4 2024, Gross Profit fell 109950132958505.31% year-over-year to -$1737594727.2 billion; the TTM figure through Dec 2024 stood at -$1737594727.2 billion (down 83615319075966.94% YoY), while the FY2025 annual figure was $3.1 million, up 41.12% from the prior year.
- Gross Profit was -$1737594727.2 billion for Q4 2024 at Immuron, down from $1.6 million in the prior quarter.
- In the past five years, Gross Profit ranged from a high of $1.6 million in Q4 2023 to a low of -$1737594727.2 billion in Q4 2024.
- Historically, Gross Profit has averaged -$289599121.2 billion across 5 years, with a median of $37175.4 in 2020.
- The sharpest annual moves came in 2022 and 2024: Gross Profit surged 36086.56% in 2022, then sank 109950132958505.31% in 2024.
- A 5-year view of Gross Profit shows it stood at $5719.6 in 2020, then slumped by 79.32% to $1182.5 in 2021, then soared by 36086.56% to $427920.0 in 2022, then surged by 269.31% to $1.6 million in 2023, then tumbled by 109950132958505.31% to -$1737594727.2 billion in 2024.
- The last three Gross Profit figures came in at -$1737594727.2 billion (Q4 2024), $1.6 million (Q4 2023), and $68631.3 (Q2 2023), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Alterity Therapeutics | 925,601.88 Bn | 925,601.85 Bn | - |
| 2 | Belite Bio | 58,560.00 Bn | 58,560.00 Bn | - |
| 3 | Quantum Biopharma | 17,284.41 Bn | 17,284.40 Bn | - |
| 4 | Legend Biotech | 2,809.00 Bn | 2,808.71 Bn | 242.10 Mn |
| 5 | Evaxion A | 1,334.43 Bn | 1,334.42 Bn | - |
| 6 | Akari Therapeutics | 1,312.27 Bn | 1,312.26 Bn | - |
| 7 | Psyence Biomedical | 212.16 Bn | 212.16 Bn | - |
| 8 | Vertex Pharmaceuticals | 114.83 Bn | 107.58 Bn | 2.59 Bn |
| 9 | Abivax | 91.96 Bn | 91.96 Bn | - |
| 10 | Immuron | 921.61 Mn | 921.58 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2024 | -1,737,594,727.21 Bn |
| Dec 31, 2024 | -1,737,594,727.21 Bn |
| Dec 31, 2023 | 1.58 Mn |
| Dec 31, 2023 | 1.58 Mn |
| Jun 30, 2023 | 68,631.26 |
| Jun 30, 2023 | 68,631.26 |
| Dec 31, 2022 | 427,920.00 |
| Dec 31, 2022 | 427,920.00 |
| Dec 31, 2021 | 1,182.54 |
| Dec 31, 2021 | 1,182.54 |
| Dec 31, 2020 | 5,719.56 |
| Dec 31, 2020 | 5,719.56 |
| Dec 31, 2019 | 11,214.25 |
| Dec 31, 2019 | 11,214.25 |
| Dec 31, 2018 | 746,754.00 |
| Dec 31, 2018 | 746,754.00 |
| Dec 31, 2017 | 564,074.12 |
| Dec 31, 2017 | 564,074.12 |
| Dec 31, 2016 | 361,687.03 |
| Dec 31, 2016 | 361,687.03 |